SG10201401305SA - Methods of predicting cancer risk using gene expression in premalignant tissue - Google Patents
Methods of predicting cancer risk using gene expression in premalignant tissueInfo
- Publication number
- SG10201401305SA SG10201401305SA SG10201401305SA SG10201401305SA SG10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- gene expression
- cancer risk
- predicting cancer
- premalignant tissue
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000014509 gene expression Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16750309P | 2009-04-07 | 2009-04-07 | |
| US24370809P | 2009-09-18 | 2009-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201401305SA true SG10201401305SA (en) | 2014-08-28 |
Family
ID=42936861
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201401305SA SG10201401305SA (en) | 2009-04-07 | 2010-04-07 | Methods of predicting cancer risk using gene expression in premalignant tissue |
| SG2011070760A SG174611A1 (en) | 2009-04-07 | 2010-04-07 | Methods of predicting cancer risk using gene expression in premalignant tissue |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2011070760A SG174611A1 (en) | 2009-04-07 | 2010-04-07 | Methods of predicting cancer risk using gene expression in premalignant tissue |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8765383B2 (en) |
| EP (1) | EP2417271A4 (en) |
| AU (1) | AU2010234456A1 (en) |
| CA (1) | CA2757927A1 (en) |
| IL (1) | IL215253A0 (en) |
| NZ (1) | NZ595356A (en) |
| SG (2) | SG10201401305SA (en) |
| WO (1) | WO2010118166A2 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1974058B1 (en) * | 2006-01-11 | 2014-06-11 | Genomic Health, Inc. | Gene expression markers for colorectal cancer prognosis |
| WO2009114836A1 (en) | 2008-03-14 | 2009-09-17 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
| SG175832A1 (en) * | 2009-05-01 | 2011-12-29 | Genomic Health Inc | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy |
| SG10201505769PA (en) | 2010-07-27 | 2015-09-29 | Genomic Health Inc | Method for using gene expression to determine prognosis of prostate cancer |
| JP2015503356A (en) | 2012-01-06 | 2015-02-02 | バイオミクス, インコーポレイテッドViomics, Inc. | System and method for detecting RNA altered by cancer in peripheral blood |
| SG10201605210PA (en) | 2012-01-31 | 2016-08-30 | Genomic Health Inc | Gene expression profile algorithm and test for determining prognosis of prostate cancer |
| CN105143882B (en) * | 2013-04-11 | 2018-10-26 | 塞托克尔公司 | Use cytology and immunologic biological sample appraisal procedure |
| WO2015138889A1 (en) * | 2014-03-13 | 2015-09-17 | The Penn State Research Foundation | Compositions and methods for diagnosing barrett's esophagus stages |
| CA2955456A1 (en) | 2014-07-17 | 2016-01-21 | Brian J. Czerniecki | Identification of immunogenic mhc class ii peptides for immune-based therapy |
| ES2838923T3 (en) | 2014-10-24 | 2021-07-02 | Koninklijke Philips Nv | Medical prognosis and prediction of response to treatment using multiple activities of the cell signaling pathway |
| AU2015334841B2 (en) | 2014-10-24 | 2022-02-03 | Koninklijke Philips N.V. | Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities |
| JP6415712B2 (en) | 2014-10-24 | 2018-10-31 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | Assessment of TGF-β cell signaling pathway activity using mathematical modeling of target gene expression |
| ITUB20150652A1 (en) | 2015-05-21 | 2016-11-21 | Univ Bologna Alma Mater Studiorum | NEW DIAGNOSTIC METHOD AND KIT |
| JP2018527286A (en) * | 2015-07-17 | 2018-09-20 | ブライアン ジェイ ツェルニキＣＺＥＲＮＩＥＣＫＩ， Ｂｒｉａｎ， Ｊ． | Identification of immunogenic MHC class II peptides for immune-based therapy |
| ES2861400T3 (en) | 2015-08-14 | 2021-10-06 | Koninklijke Philips Nv | Evaluation of the activity of the NFkB cell signaling pathway using mathematical models of target gene expression |
| EP3461916A1 (en) | 2017-10-02 | 2019-04-03 | Koninklijke Philips N.V. | Assessment of jak-stat3 cellular signaling pathway activity using mathematical modelling of target gene expression |
| EP3461915A1 (en) | 2017-10-02 | 2019-04-03 | Koninklijke Philips N.V. | Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression |
| EP3502279A1 (en) | 2017-12-20 | 2019-06-26 | Koninklijke Philips N.V. | Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953658B2 (en) | 2000-03-09 | 2005-10-11 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer |
| US7622260B2 (en) | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
| US7955800B2 (en) | 2002-06-25 | 2011-06-07 | Advpharma Inc. | Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients |
| US20040053317A1 (en) | 2002-09-10 | 2004-03-18 | Sidney Kimmel Cancer Center | Gene segregation and biological sample classification methods |
| WO2005076005A2 (en) | 2004-01-30 | 2005-08-18 | Medizinische Universität Wien | A method for classifying a tumor cell sample based upon differential expression of at least two genes |
| EP1907858A4 (en) | 2005-06-13 | 2009-04-08 | Univ Michigan | COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER |
| US20070099209A1 (en) | 2005-06-13 | 2007-05-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| WO2007025044A2 (en) | 2005-08-24 | 2007-03-01 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators |
| EP1974058B1 (en) | 2006-01-11 | 2014-06-11 | Genomic Health, Inc. | Gene expression markers for colorectal cancer prognosis |
| US7812143B2 (en) | 2006-03-31 | 2010-10-12 | Memorial Sloan-Kettering Cancer Center | Biomarkers for cancer treatment |
| NZ562237A (en) | 2007-10-05 | 2011-02-25 | Pacific Edge Biotechnology Ltd | Proliferation signature and prognosis for gastrointestinal cancer |
| CA2723984A1 (en) | 2008-05-14 | 2009-11-19 | Genomic Health Inc. | Predictors of patient response to treatment with egf receptor inhibitors |
| CN102159729B (en) * | 2008-09-22 | 2015-07-15 | 怡发科技股份有限公司 | Molecular markers of lung and colorectal cancer |
-
2010
- 2010-04-06 US US12/755,368 patent/US8765383B2/en active Active
- 2010-04-07 WO PCT/US2010/030285 patent/WO2010118166A2/en not_active Ceased
- 2010-04-07 AU AU2010234456A patent/AU2010234456A1/en not_active Abandoned
- 2010-04-07 SG SG10201401305SA patent/SG10201401305SA/en unknown
- 2010-04-07 NZ NZ595356A patent/NZ595356A/en unknown
- 2010-04-07 CA CA2757927A patent/CA2757927A1/en not_active Abandoned
- 2010-04-07 EP EP10762395A patent/EP2417271A4/en not_active Withdrawn
- 2010-04-07 SG SG2011070760A patent/SG174611A1/en unknown
-
2011
- 2011-09-20 IL IL215253A patent/IL215253A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2417271A2 (en) | 2012-02-15 |
| SG174611A1 (en) | 2011-11-28 |
| WO2010118166A3 (en) | 2011-03-17 |
| US8765383B2 (en) | 2014-07-01 |
| NZ595356A (en) | 2013-07-26 |
| AU2010234456A1 (en) | 2011-10-20 |
| US20100291573A1 (en) | 2010-11-18 |
| WO2010118166A2 (en) | 2010-10-14 |
| EP2417271A4 (en) | 2012-08-29 |
| CA2757927A1 (en) | 2010-10-14 |
| IL215253A0 (en) | 2011-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201401305SA (en) | Methods of predicting cancer risk using gene expression in premalignant tissue | |
| IL276487B (en) | Methods to predict clinical outcome of cancer | |
| IL256335B (en) | Method to use gene expression to determine likelihood of clinical outcome of renal cancer | |
| IL218575A0 (en) | Treatment of cancer | |
| IL258794B (en) | Methods and compositions for diagnosis and treatment of cancer | |
| EP2389573A4 (en) | Skin analysis methods | |
| IL209855A0 (en) | Supression of neuroedocrine diseases | |
| ZA201105472B (en) | Methods and compositions for diagnosis and treatment of cancer | |
| IL216627A0 (en) | Methods for breast cancer risk assessment | |
| EP2438197A4 (en) | Methods of detecting cancer | |
| EP2373794A4 (en) | Nectin-4 for target genes of cancer therapy and diagnosis | |
| PL2435825T3 (en) | Methods of treating diseases | |
| IL218964A0 (en) | Phototriggered nanoparticles for cell and tissue targeting | |
| EP2491958A4 (en) | Material for induction of hard tissue regeneration | |
| ZA201305274B (en) | Data analysis of dna sequences | |
| EP2398901A4 (en) | Jarid1b for target gene of cancer therapy and diagnosis | |
| EP2402053A4 (en) | Electrohydraulic prostate tissue treatment probe | |
| GB0908788D0 (en) | Tissue analysis | |
| EP2470903A4 (en) | Gene and polypeptide relating to breast cancer | |
| GB0916686D0 (en) | Treatment of cancer | |
| EP2478843A4 (en) | Ultrasonograph and method of diagnosis using same | |
| EP2350276A4 (en) | Syngr4 for target genes of cancer therapy and diagnosis | |
| HK1167006A (en) | Methods of predicting cancer risk using gene expression in premalignant tissue | |
| EP2262541A4 (en) | C2orf18 as target gene for cancer therapy and diagnosis | |
| GB0913976D0 (en) | Method of performing market research |